2020
DOI: 10.1002/anie.202005124
|View full text |Cite
|
Sign up to set email alerts
|

Harnessing Effective Molarity to Design an Electrochemical DNA‐based Platform for Clinically Relevant Antibody Detection

Abstract: Easy‐to‐use platforms for rapid antibody detection are likely to improve molecular diagnostics and immunotherapy monitoring. However, current technologies require multi‐step, time‐consuming procedures that limit their applicability in these fields. Herein, we demonstrate effective molarity‐driven electrochemical DNA‐based detection of target antibodies. We show a highly selective, signal‐on DNA‐based sensor that takes advantage of antibody‐binding‐induced increase of local concentration to detect clinically re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 31 publications
(25 citation statements)
references
References 74 publications
0
25
0
Order By: Relevance
“…[ 5 , 6 , 7 , 8 , 9 , 10 , 11 ] Sensitivity is a key consideration for many biomedical applications, because many clinical biomarkers are present at nanomolar to picomolar concentrations, and the biosensor must achieve sufficient sensitivity in a complex background of interferent molecules. [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ] Unfortunately, due to noise limitations in existing electronic measurement systems, the signal‐to‐noise ratio of conventional electrochemical biosensors degrades precipitously when they are miniaturized to the micron scale, [ 21 ] reducing their sensitivity and making meaningful measurements of analyte concentrations challenging or even impossible in many cases. [ 22 , 23 ]…”
Section: Introductionmentioning
confidence: 99%
“…[ 5 , 6 , 7 , 8 , 9 , 10 , 11 ] Sensitivity is a key consideration for many biomedical applications, because many clinical biomarkers are present at nanomolar to picomolar concentrations, and the biosensor must achieve sufficient sensitivity in a complex background of interferent molecules. [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 ] Unfortunately, due to noise limitations in existing electronic measurement systems, the signal‐to‐noise ratio of conventional electrochemical biosensors degrades precipitously when they are miniaturized to the micron scale, [ 21 ] reducing their sensitivity and making meaningful measurements of analyte concentrations challenging or even impossible in many cases. [ 22 , 23 ]…”
Section: Introductionmentioning
confidence: 99%
“…The products of the toehold displacement reaction formed a heterodimer which included two copies of the surface hybridization strand, thereby generating bivalent affinity to the surface which stabilized the binding for EC readout. Recently, Porchetta and co-workers, referring to the proximity effect as “effective molarity”, carefully tuned their system for rapid antibody detection. As shown in Figure A (top), a low affinity hybridization interaction between the capture strand and the output strand could be enhanced by a bivalent antibody mimicking strand (Ab-mimic) similar to DNA loops developed previously. ,, This experimental model clearly shows the enhancement given by the proximity effect, where the response curve was shifted to lower concentrations in the presence of the Ab-mimic (red curve).…”
Section: Dna Based Probe Proximity For Biosensingmentioning
confidence: 99%
“…The researchers then applied the concept to quantify bivalent antibodies, as shown in Figure A (bottom), to give a modular and rapid EC approach based on the proximity effect. Both IgG and IgE antibody classes could be detected, and the sensor was validated with four different clinically relevant antibodies in bodily fluids …”
Section: Dna Based Probe Proximity For Biosensingmentioning
confidence: 99%
See 2 more Smart Citations